Phase I trial of intramural injection of DTI-015 [carmustine] for recurrent malignant gliomas
Phase of Trial: Phase I/II
Latest Information Update: 20 Oct 2010
At a glance
- Drugs Carmustine (Primary)
- Indications Anaplastic astrocytoma; Ependymoma; Glioblastoma; Glioma
- Focus Adverse reactions; Therapeutic Use
- 20 Oct 2010 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 20 Oct 2010 Actual end date (August 2005) added as reported by ClinicalTrials.gov.
- 27 Sep 2005 New trial record.